Best Stem cell therapy pediatricians: TOP 155 doctors

el count and C-reactive protein levels. Anadolu Kardiyoloji Dergisi. 2011;11(2):105-111. 24. Aytekin M., Tonelli A., Farver C., Dweik R.: Leptin deficiency promotes pulmonary arterial hypertension in mice. American Thoracic Society International Conference. 2011. 25. Kalay N., Aytekin M., Kaya MG., Ozbek K., Karayakali M., Sogut E., Altunkas F., Ozturk A., Koc F.: Plasma trace element levels and slow coronary flow in acute coronary syndrome. American Thoracic Society International Conference. 2011. 26. Kalay N., Aytekin M., Kaya MG., Ozbek K., Karayakali M., Sogut E., Altunkas F., Ozturk A., Koc F.: Slow coronary flow and hyperhomocysteinemia. American Journal of Cardiology. 2011;107(9):1443-1448. 27. Aytekin M., Mashir A., Farver C., Paschke K., Storer M., Dweik RA.: Exhaled breath analysis: from sensors to devices and applications. American Thoracic Society International Conference. 2010. 28. Aytekin M., Tonelli A., Farver C., Dweik RA.: Leptin deficiency promotes pulmonary arterial hypertension in mice. American Thoracic Society International Conference. 2010. 29. Aytekin M., Farver C., Comhair SA., Paschke KM., Storer M., Dweik RA.: Exhaled breath analysis in idiopathic pulmonary arterial hypertension. American Thoracic Society International Conference. 2009. Assoc. Prof. Dr. Metin Aytekin is a Clinical Biochemist and Molecular Medicine specialist with Adjunct position in the Department of Pathobiology of Cleveland Clinic, Cleveland/USA. He is an Associate Prof. at Erciyes University, Kayseri/Turkey and Vice President of Genome and Stem Cell Center (GENKÖK). He has been honored numerous times for his research and publications, and has published many peer-reviewed articles related to lung diseases, pulmonary hypertension, coronary atherosclerosis, and anthracycline-related cardiotoxicity.